Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbacterium oxydans. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN102382780A reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain stability for global API manufacturers.